Login to Your Account

Celldex Extending Pipeline, Cash Runway in $95M CuraGen Deal

By Catherine Hollingsworth

Monday, June 1, 2009
Celldex Therapeutics Inc. took another step toward expanding its pipeline, agreeing to buy CuraGen Corp. in a $94.5 million stock deal that will bring in 11 drug candidates and some added cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription